Trademark: 90489339
Status Date
Friday, February 2, 2024
Filing Date
Tuesday, January 26, 2021
Published for Opposition
Tuesday, January 4, 2022
5 Pharmaceutical preparations for the treatment and prevention of cancer, oncological diseases, leukemia, metastasis, musculoskeletal disorders, muscular dystrophy, pseudoxanthoma, dermatological disorders, allergy, cardiovascular diseases, kidney diseases
Feb 6, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 2, 2024
Sou Extension 4 Granted
Feb 2, 2024
Sou Extension 4 Filed
Feb 2, 2024
Sou Teas Extension Received
Aug 24, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 22, 2023
Sou Extension 3 Granted
Aug 22, 2023
Sou Extension 3 Filed
Aug 22, 2023
Sou Teas Extension Received
Feb 4, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 2, 2023
Sou Extension 2 Granted
Feb 2, 2023
Sou Extension 2 Filed
Feb 2, 2023
Sou Teas Extension Received
Jul 26, 2022
Notice Of Approval Of Extension Request E-Mailed
Jul 22, 2022
Sou Extension 1 Granted
Jul 22, 2022
Sou Extension 1 Filed
Jul 22, 2022
Sou Teas Extension Received
Mar 1, 2022
Noa E-Mailed - Sou Required From Applicant
Jan 4, 2022
Official Gazette Publication Confirmation E-Mailed
Jan 4, 2022
Published For Opposition
Dec 15, 2021
Notification Of Notice Of Publication E-Mailed
Dec 1, 2021
Law Office Publication Review Completed
Dec 1, 2021
Approved For Pub - Principal Register
Oct 25, 2021
Teas/Email Correspondence Entered
Oct 25, 2021
Correspondence Received In Law Office
Oct 25, 2021
Assigned To Lie
Oct 19, 2021
Teas Response To Suspension Inquiry Received
Aug 15, 2021
Notification Of Letter Of Suspension E-Mailed
Aug 15, 2021
Letter Of Suspension E-Mailed
Aug 15, 2021
Suspension Letter Written
Aug 12, 2021
Assigned To Examiner
Apr 27, 2021
New Application Office Supplied Data Entered
Jan 29, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
